Deven Parmar, MD
Zydus Therapeutics Inc. · Zydus Lifesciences Ltd (formerly Known as Cadila Healthcare Ltd) · Cadila Healthcare Ltd.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
19
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
NIH RePORTER
Trial papers
0
PubMed author-name match
Trials
Studies that name Deven Parmar, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:26 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06398808 · A Study to Evaluate the Efficacy and Safety of ZYIL1 Oral Capsules for the Treatment of Patients With Mild to Moderately Active Ulcerative Colitis Resistant or Intolerant to Oral AminosalicylatesZydus Lifesciences Limited · completed · Ulcerative Colitis · study chair
- Ph2NCT05981040 · Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ZYIL1 in Patients With Amyotrophic Lateral SclerosisZydus Lifesciences Limited · completed · Amyotrophic Lateral Sclerosis · study chair
- Ph1NCT05911828 · A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combination ZY19489-Ferroquine in Adult Asymptomatic Plasmodium Falciparum CarriersZydus Lifesciences Limited · unknown · Uncomplicated Malaria, Asymptomatic Condition, Falciparum Malaria · study director
- Ph4NCT05872269 · A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With ComorbiditiesZydus Lifesciences Limited · unknown · NAFLD, Obesity, Type 2 Diabetes · study chair
- Ph4NCT05515367 · A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).(Real World Evidence Study)Zydus Lifesciences Limited · recruiting · Chronic Kidney Diseases, Anemia of Chronic Kidney Disease · study chair
- Ph3NCT05283837 · A Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Immunogenicity of Test Pertuzumab (ZRC-3277, Cadila Healthcare Ltd.,)Zydus Lifesciences Limited · completed · Metastatic Breast Cancer · study director
- Ph1NCT05206201 · A Study Of Zy-19489 Administered Via Oral Route To Investigate The Safety, Tolerability And Pharmacokinetics In Healthy Adult Human SubjectsZydus Lifesciences Limited · completed · Malaria · study chair
- Ph2NCT05186051 · A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZYIL1 in Subjects With Cryopyrin Associated Periodic Syndromes (CAPS)Zydus Lifesciences Limited · completed · Cryopyrin Associated Periodic Syndrome · study director
- Ph1NCT04972188 · A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ZYIL1 Following Oral Administration in Healthy VolunteersZydus Lifesciences Limited · completed · Healthy · study chair
- Ph1NCT04731324 · Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ZYIL1 Following Oral Administration in Healthy VolunteersZydus Lifesciences Limited · completed · Healthy · study chair
- Ph1NCT04667533 · Desidustat in the Treatment of Chemotherapy Induced AnemiaZydus Lifesciences Limited · completed · Anemia of Chronic Kidney Disease, Chemotherapy Effect · study chair
- Ph2NCT04480138 · Pegylated Interferon - α2b With SARSCoV- 2 (COVID-19)Zydus Lifesciences Limited · terminated · Covid19 · study director
- Ph1NCT04469920 · Hepatic Impairment, Cholestatic Liver Disease, & NASH with Advanced Fibrosis & Normal Hepatic FunctionZydus Therapeutics Inc. · completed · Hepatic Impairment · study director
- Ph2NCT04463602 · Desidustat in the Management of COVID-19 PatientsZydus Lifesciences Limited · completed · COVID-19 · study director
- Ph1NCT04446507 · A Pharmacokinetic Study of Saroglitazar Magnesium in Subjects with Severe Renal Impairment and Normal Renal FunctionZydus Therapeutics Inc. · completed · Renal Impairment · study director
- Ph3NCT04215120 · Desidustat in the Treatment of Anemia in CKD on Dialysis PatientsZydus Lifesciences Limited · completed · Chronic Kidney Disease Stage 5 on Dialysis · study director
- Ph2NCT03639623 · Safety, Tolerability, and Efficacy of Saroglitazar Mg 4 mg in Liver Transplant Recipients With Nonalcoholic Fatty Liver Disease (NAFLD)Zydus Therapeutics Inc. · completed · Liver Transplant; Complications, NAFLD · study director
- Ph2NCT03617263 · Saroglitazar Magnesium 4 mg in the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in Women With PCOS (EVIDENCES VII)Zydus Therapeutics Inc. · terminated · Non-alcoholic Fatty Liver Disease in Women With PCOS · study director
- Ph2NCT03112681 · Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Mg in Patients With Primary Biliary CholangitisZydus Therapeutics Inc. · completed · Primary Biliary Cirrhosis · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:26 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.